A profitable, fully remote cash-pay telehealth platform providing medical weight loss (GLP-1 therapies) and longevity care nationwide. Founded 2022. Trailing twelve-month revenue of $1,821,000 (up 36% year over year) at a 66% gross margin, generating $633,000 in seller's discretionary earnings.
The business acquires patients through a network of social-media affiliates paid a 10% lifetime revenue share — it has never relied on paid advertising. In-house nurse practitioners, licensed across all 50 states, review each intake and prescribe to protocol; partner compounding pharmacies drop-ship 3–6 month plans direct to the patient. There is no inventory, no premises, and no capital equipment.
Key selling points:
- Revenue grew from $539,000 (FY2023) to $1,821,000 (TTM), with monthly revenue roughly doubling in the four months after an affiliate manager was hired
- No customer concentration — no single customer exceeds 1% of revenue
- Diversified mix: approximately 60% weight loss, 40% longevity, with longevity growing fastest
- Owner works about five hours per month; a full-time operator runs the business day to day
- A 45,000-member community group, brand, and clinical protocols are included in the sale
- Clear, capital-light growth paths: product extensions, B2B referral partnerships, and entry into the insurance channel
The owner is selling to bring in new operating energy for the next phase and will support a 90–180 day transition, with the option to retain a minority stake.
